Skip to main content
Novartis
language-selector-globe
Choose location
language-selector-globeCanada | en |
EnglishFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose location
language-selector-globeCanada
EnglishFrançais
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Canada 
      • Diversity, Equity and Inclusion 
      • Executive Committee 
      • People and Culture 
      • Therapeutic Areas 
      • Products 
      • Our people Stories 
      • Contact Us 
      Woman and man looking at laptop
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Patient perspective Stories 
      • Grants and Donations 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • HCP Portal 
      • Products 
      • Pipeline (EN) 
      • Adverse Event Reporting 
      • Clinical Trials 
      • Novartis Clinical Trials 
      • Disclosure Of Payments To Healthcare Professionals 
      Healthcare Professionals Header Image
      Healthcare Professionals
    • ESG 
      • Access 
      • Ethics, Risk and Compliance 
      • Grants and Donations 
      • Health Equity Initiative 
        • Guidelines and Eligibility Criteria 
        • About the Novartis Health Equity Initiative 
        • Past Winners 
        • Online Application 
      • Corporate Responsibility 
        • AODA Compliant - EN (PDF 0.2 MB) 
        • AODA Compliant - FR (PDF 0.2 MB) 
        • AMA Compliant - EN (PDF 0.2 MB) 
        • AMA Compliant - FR (PDF 0.2 MB)  
        • Disclosure Of Payments To Healthcare Professionals 
        • Environmental Sustainability 
      • Reporting and Transparency Hub 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Our people Stories 
      • Website Privacy Policy 
      • General Privacy Notice for Business Partners 
      • General Privacy Notice for Third Parties 
      • General Privacy Notice for External Stakeholders 
      • Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints 
    • Careers 
      • Diversity, Equity and Inclusion 
      • People and Culture 
      • Career Search 
      • How We Work 
      • Well-being 
      Two women chatting
      Careers
    • Contact Us 
Header
Environment, Society and Governance

Environment, Society and Governance

As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
Ethical Behaviour header

Ethical Behaviour

At Novartis, we hold ourselves to high ethical standards and do not tolerate unethical behavior.
Grants & Donations

Grants and Donations

Novartis Canada is deeply committed to providing support to organizations that deliver real benefits to our communities and beyond.
People seating outside

Corporate Responsibility

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues.
Health Equity in Canada

Novartis Health Equity Initiative

A $500,000 CAD fund to help promote equal access to healthcare in Canada. We invite all eligible organizations to apply for funding.

Novartis Canada

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis Websites
  • Global site
  • HCP Portal
Footer Bottom
© 2026 Novartis AG
  • Terms of Use
  • Privacy
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Canada.